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Abstract 
Background: Abnormalities in reward circuit function are considered a core feature of 
addiction. Yet, it is still largely unknown whether these abnormalities stem from chronic drug 
use, a genetic predisposition, or both. Methods: In the present study, we investigated this issue 
using a large sample of adolescent children by applying structural equation modeling to examine 
the effects of several dopaminergic polymorphisms of the D1 and D2 receptor type on the reward 
function of the ventral striatum and orbital frontal cortex, and whether this relationship predicted 
the propensity to engage in early alcohol misuse behaviours at 14 years of age and again at 16 
years of age. Results: The results demonstrated a regional specificity with which the functional 
polymorphism rs686 of the DRD1 gene and Taq1A of the ANKK1 gene influenced medial and 
lateral orbital frontal cortex activation during reward anticipation, respectively. Importantly, our 
path model revealed a significant indirect relationship between the rs686 of the DRD1 gene and 
early onset of alcohol misuse through a medial orbital frontal cortex and the ventral striatum 
interaction. Conclusions: These findings highlight the role of D1 and D2 in adjusting reward-
related activations within the mesocorticolimbic circuitry, as well as in the susceptibility to early 
onset of alcohol misuse. 
 
… 
Keywords: adolescence; dopamine D1/D2 receptor; ventral striatum; orbital frontal cortex; 
reward; addiction;  
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Introduction 
More than a decade of neuroimaging studies point towards functional abnormalities of 
the mesocorticolimbic reward system in substance use disorders (Redish et al., 2008, Volkow et 
al., 2009). Overall, the data imply that chronic drug use can lead to increased neuronal activation 
in response to drug-associated cues, and reduced response to natural rewards, a maladaptive 
process thought to facilitate the progression towards excessive drug choice (Volkow et al., 2009). 
While much attention in the field has focused on identifying addiction-related endophenotypes 
contributing to pre-existing abnormalities in reward circuit function, the search has been plagued 
by questions of causality: Do the observed reward-related abnormalities stem from chronic drug 
use itself, or from factors related to genetics that facilitate a progression towards excessive drug 
use, or some combination of both? Of importance, the longitudinal path from a potential genetic 
vulnerability to substance misuse outcomes later in life have not been investigated from such a 
neurodevelopmental perspective, due, in part, to the lack of sufficiently powered longitudinal 
genetic-neuroimaging studies (Conrod and Nikolaou, 2016). 
Using a uniquely large genetic-neuroimaging dataset (IMAGEN study (Schumann et al., 
2010), we addressed this unsolved issue by applying structural equation modeling [SEM]) to 
examine whether the selective modulation of key components of the reward circuitry –ventral 
striatum (VS) and orbital frontal cortex (OFC) – by dopaminergic functional polymorphisms 
contribute to the degree of perilous alcohol use behaviour observed at 14 years of age and again 
at 16 years of age. In particular, functional magnetic resonance imaging (fMRI) data collected 
from 14 year old adolescence participants performing the monetary incentive delay (MID) task 
were used to quantify the blood-oxygen-level dependent (BOLD) response of the VS and OFC 
during the anticipation of large and small rewards. The MID task has been used extensively to 
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investigate changes in neural activity in response to the processing of different stages of reward 
processing (e.g. reward prediction, anticipation of obtaining rewards of different magnitude or 
avoiding punishment, outcome processing) in typical and atypical populations, with findings that 
converge with both animal and human studies emphasizing the essential role of the VS and OFC 
in processing reward-related information (for review, see (Lutz & Widmer, 2014; Balodis & 
Potenza, 2015; Knutson & Heinz, 2015). However, both hypo-responsiveness and hyper-
responsiveness of reward-related brain regions (e.g., VS) have been reported during anticipation 
of reward in the MID task in substance dependent adults (for review, see (Balodis and Potenza, 
2015), so it remains uncertain what functional state (hyper vs hypo) of the reward system may 
actually precipitate a substance use disorder.     
Nevertheless, the relevant reward signal (i.e. positive and negative reward prediction 
error signals) critical to the functioning of the VS and OFC are thought to originate in the 
midbrain dopamine system (Schultz, 2001; Schultz et al., 2000). These reward signals are 
conveyed to the neural targets of the dopamine system where their impact reorganizes synaptic 
connectivity in a way that drives learning and motivation (Schultz, 2011, Schultz, 2001). For this 
reason, we focused on functional polymorphisms that would appear to alter dopaminergic 
signaling in the VS and OFC during reward valuation and prediction. To be specific, we selected 
the 7-SNP haplotype of the PPP1R1B gene − mRNA expression highest for G alleles of the 
rs87694 SNP (Meyer-Lindenberg et al., 2007) – because of its critical function in integrating 
dopaminergic and glutaminergic signaling (Svenningsson et al., 2004), and its association with 
reward learning (Frank et al., 2007) and cognitive performance (Meyer-Lindenberg et al., 2007). 
The rs686 SNP of the DRD1−the G allele linked to increases in DRD1 expression (Huang and 
Li, 2009) – selected because of the role D1 has in reward signalling (Ikemoto et al., 1997; Suhara 
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& Miyoshi, 2007) and addiction (Batel et al., 2008; Comings et al., 1997; Zhu et al., 2013; 
Huang et al., 2008). To date, the rs686 SNP of the DRD1 has yet to be investigated in the context 
of human reward-related learning or behaviour. Further, we selected the promoter rs12364283 
SNP of the DRD2 gene – the C allele has been shown to confer higher transcriptional activity 
(Zhang et al., 2007)− because of the association D2 has with reward signalling (Assadi et al., 
2009; Suhara & Miyoshi, 2007), reinforcement learning  (Baker et al., 2013; Frank & Hutchison, 
2009), and addiction (Noble, 1994; Noble, 2000).  Likewise, the Taq1A polymorphism 
(rs1800497) of the ANKK1 gene was also selected because of its association with striatal D2 
receptor function (Thompson et al., 1997) but see (Laruelle et al., 1998), altered activation of 
OFC (Cohen et al., 2005) and VS (Nymberg et al., 2014), impaired reinforcement learning 
(Klein et al., 2007), and addiction (Munafo et al., 2007; Noble et al., 1994; Abi-Dargham, 2004; 
Noble, 1998; Noble, 2003; Noble, 2000).  
Taken together, we hypothesized that these specific dopaminergic functional 
polymorphisms  − DRD1rs686, DRD2rs12364283, ANKK1rs1800497, and PPP1R1Brs87694 – may 
selectively modulate the VS and OFC BOLD signal (hyper vs hypo) during reward anticipation. 
In turn, we predicted that the relationship between these SNPs and alcohol related behaviour at 
14 years and 16 years of age would be indirect and be mediated by their effect on the reward 
response in these selected brain regions. Although less explored, because both the VS and OFC 
have been proposed to play an important role in reward learning (Frank & Claus, 2006), 
adolescent risk-taking behaviours (Galvan et al., 2006; Conrod & Nikolaou, 2016) and the 
development of addiction (Pujara & Koenigs, 2014), we used an interaction term to investigate 
the influence of the balance of activity between these two regions during reward anticipation as a 
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variable of interest in our SEM. Our proposed imaging genetics approach constitutes a natural 
application of SEM, which provides a means for modeling such complex interrelationships. 
Methods 
Participants and Procedure 
A community-based sample of young adolescents (N=2463) was recruited for the 
IMAGEN study (for details on the IMAGEN project, see Schumann et al. 2010). Individuals 
who provided assent, and whose parents provided informed written consent, completed an 
extensive battery of neuropsychological, clinical, personality and drug use assessments online 
and at the testing centers. Participants were excluded if, among other criteria, they had contra-
indications for MRI (for example, metal implants, claustrophobia). After data quality control, 
complete and reliable data sets were available for 1840 participants at Time 1 (1666 participants 
at Time 2). Of these volunteers at Time 2, 1639 had complete neuroimaging data. The 
demographic information of the participants at time 1 was: mean age = 14.55 ± 0.447 years, 
51.7% female, 88.80% right-handed, verbal IQ = 110.67 ± 14.85, performance IQ = 107.57 ± 
14.77.  
Alcohol Use Disorders Identification Test  
Problematic alcohol use behaviors were assessed twice, at 14 and 16 years of age, using 
the total score of the Alcohol Use Disorders Identification Test (AUDIT) (Bohn et al. 1995) via 
the online computer Psytools ® (Delosis Ltd, London, UK) platforms at the participant’s home. 
Of the 1840 adolescents in Time 1 (AUDIT mean = 1.56 ± 0.06), 877 scored 0 on the AUDIT 
and thus had never used alcohol, whereas 963 adolescents reported the use of alcohol at some 
degree (score >0) (Table 1). Of the 1666 adolescents in Time 2 (AUDIT mean = 3.7 ± 0.08), 288 
scored 0 on the AUDIT and thus had never used alcohol, whereas 1378 adolescents reported the 
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use of alcohol (score >0) (for an overview of these data, see Table 1). To note, participants 
AUDIT score were significantly larger at Time 2 compared to Time 1, t(1461) = -25.8, p < .001.  
***Table1*** 
fMRI task, acquisition and analysis  
Monetary incentive delay task In order to assess reward processing during fMRI in an 
adolescence population, a modified version of the MID task was used (Figure 1). In brief, each 
trial consisted of anticipation, response, and feedback related cues. Before the anticipation phase, 
a cue signaled the position of the target as well as the type of reward that could be attained by a 
correct response. Different cues distinguished between large reward (10 points), small reward (2 
points) and neutral (zero points) conditions. After a random anticipation interval of 4000–
4500ms length, the target appeared. Participants were instructed to respond to the target as 
quickly as possible via button press and informed that the points they earned would be converted 
into chocolate treats after scanning (i.e. 1 candy [M&Ms] for every 5 points scored). The 
duration of the target was continuously adapted to the performance of the subject, ensuring a 
successful performance on approximately 66% of all the trials. Immediately following the 
response, feedback indicated the number of points attained in the recent trial as well as the total 
points earned during the task. The inter-trial interval varied so that each trial took approximately 
10,000 ms (Figure 1). Large, small, and neutral conditions were randomized throughout the task 
(22 trials each, summing up to 66 trials in total). Task presentation and recording of the 
behavioral responses were performed using Visual Basic 2005 and NET Framework Version 2.0, 
as well as the visual and response grip system from Nordic Neuro Lab (NordicNeuroLab AS, 
Bergen, Norway). 
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*** Figure 1. Here*** 
 
Figure 1. Monetary Incentive Delay (MID) task, adapted from Knutson et al (2001). 
Imaging parameters All scanning was performed with a 3T whole body MRI system 
made by several manufacturers (Siemens, Philips, General Electric, Bruker) at the eight 
IMAGEN assessment sites (London, Nottingham, Dublin, Mannheim, Dresden, Berlin, 
Hamburg, and Paris). To ensure a comparison of MRI data acquired on these different scanners, 
we implemented image-acquisition techniques using a set of parameters compatible with all 
scanners that were held constant across sites (cf., Schumann et al, 2010). We acquired 40 slices 
in descending order (2.4 mm, 1 mm gap) using a gradient-echo T2*-weighted sequence (EPI) 
with the following image parameters: TR=2200 ms, TE=30 ms, and an in-plane matrix size of 64 
× 64 pixels. We used a plane of acquisition tilted to the anterior–posterior commissure line 
(rostral>caudal). For anatomical reference, a 3D magnetization prepared gradient-echo sequence 
(MPRAGE) based on the ADNI protocol (http://www.loni.ucla.edu/ADNI/Cores/index.shtml) 
with TR=6.8 ms and TE=3.2 ms over the whole brain was carried out.  
Functional preprocessing and analysis The fMRI data were analyzed with Statistical 
Parametric Mapping (SPM8, Wellcome Department of Imaging Neuroscience, University 
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College London, London, UK). All individual data were slice time corrected using the first slice 
as reference, then spatially realigned to correct for head movement, and non-linearly warped on 
the MNI space using custom EPI template based on an average of mean images of 400 
adolescents. This custom template image (53 × 63 × 46 voxels) was subsequently applied to all 
functional T2* data and voxels were resampled at a resolution of 3 × 3 × 3 mm. The functional 
data were smoothed using an isotropic Gaussian kernel for group analysis (5 mm full-width at 
half-maximum). First level statistics were performed by modeling reward anticipation and 
reward feedback as predictor variables within the context of the GLM on a voxel-by-voxel basis, 
with AR noise model against a design matrix. Estimated movement was added to the design 
matrix in the form of 18 additional columns (3 translational, 3 rotations, 3 quadratic and 3 cubic 
translations, 3 translations shifted 1 TR before, and 3 translations shifted 1 TR later). A 
movement threshold of 2 mm was employed. Furthermore, each individual fMRI time series 
underwent an automatic spike detection method.  
For anticipation cues of neutral, small reward, and large reward, as well as information 
on feedback (hit [response within the correct time window] vs missed [response outside the correct time window]) trials, 
were entered in a parametric design, and study center was included as a covariate. The regressors 
modeling the experimental conditions (e.g. cues predicting large reward, small reward, and 
neutral reward trials) were convolved using SPM's default hemodynamic response function. The 
individual contrast images were entered in a second-level random-effects analysis (full flexible 
procedure of SPM8), and a non-sphericity correction was performed. A one-sample t-test was 
conducted, testing activity on large reward trials (and separately on small reward trials) against 
the implicit baseline of the neutral condition, removing variance associated with the other 
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regressors in the design matrix. A significance level of p<0.05 was selected (FWE-corrected), 
with a minimum cluster size of 10 voxels.  
Based on previous IMAGEN studies, (cf., Nees et al, 2012, Whelan et al. 2012), the 
analyses focused on weighted mean BOLD signal change of the designated ROIs (OFC and VS) 
over both hemispheres for anticipation of large reward vs neutral (large reward condition) and 
anticipation of small reward vs neutral (small reward conditions). Furthermore, we analyzed two 
distinct regions in OFC (medial OFC and lateral OFC) based on evidence suggesting dissociable 
functions in reward processing (Elliott et al., 2000; Elliott et al., 2008; Frank & Claus, 2006) 
(O'Doherty et al., 2001; Diekhof et al., 2012). The ROI masks were taken from the Wake Forest 
University Pick-Atlas (Maldjian et al. 2003) using various atlases (medial OFC [aal atlas], lateral 
OFC [Broadman’s area 47], ventral striatum [nucleus accumbens]), and the mean contrast value for each ROI 
was calculated for each subject for both large reward and small reward contrasts1.  To note, only 
trials that subjects made a successful response were included in this analysis and our analysis 
focused on the reward anticipation period of the task. 
Genetic data 
*** Table 2. *** 
After quality control, genome-wide data were available for N=1,839 of the participants.  
Details of quality control procedures are available in the supplementary online material. We 
investigated 4 SNPs, which were selected from each member of the full set of autosomal 
catecholamine genes; namely, those that that have empirical support for variation in the 
                                                          
1 The ROIs are available from the corresponding author upon request [TEB] 
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degradation and receptor signalling of dopamine D1 and D2 receptors. In brief, we focused on 
two functional polymorphisms related to D1 receptors (DRD1rs686, PPP1R1Brs87694), and two 
genetic polymorphisms that affect D2 expression (DRD2rs12364283, ANKK1rs1800497).  
Statistical analysis strategy 
We performed two main sets of analyses using SPSS 17.0.1 and MPlus version 6.12 
(Muthen & Muthen 2011). First, a simple regression analysis was performed to identify unique 
relationships between genetic data (DRD1rs686, DRD2rs12364283, ANKK1rs1800497, and 
PPP1R1Brs87694) and neuroimaging data (medial/lateral OFC and VS), and between 
neuroimaging data and alcohol misuse at 14 and 16 years. In addition, interactions terms (medial 
OFC*VS and lateral OFC * VS) were derived from the product of the medial/lateral OFC and 
VS standardized scores  in order to examine whether the interaction between the two reward 
regions contribute to the prediction of alcohol misuse scores. Type 1 errors were statistically 
controlled following Benjamin and Hochberg (1995) with a corrected significance level of α = 
0.05. Sex, age, and imaging site (8 sites) were included in each regression model as nuisance 
variables using a stepwise approach.  
Second, a SEM path model in Mplus was conducted, in which: 1) the robustness of these 
gene-brain associations could be tested once all associations were entered simultaneously in one 
model, and the effect of sex, age, and imaging site (as a cluster variable) was controlled for; and 
2) indirect effects from genes to substance use behaviours could be tested using the product of 
coefficients method (Tofighi & MacKinnon, 2011). Full information maximum likelihood 
(FIML) was used to account for missing data. The SEM model was fit using a complex random 
effects design to control for sex, age, and site, and robust maximum likelihood estimation 
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(MLR), which is robust to non-normality. Model fit was assessed with the Chi-square and 
Comparative Fit Indices (CFI), the Standardized Root Mean Square Residual (SRMR) and the 
Root Mean Square Error of Approximation (RMSEA). Hu and Bentler (1999) suggest the 
following guidelines for interpreting Goodness-of-Fit Indices: SRMR and values close to or 
below .08, RMSEA values close to or below .06 and CFI close to or above .90 indicate 
acceptable model fit. To help interpret the interaction effects, these were plotted based on 
procedures by Aiken and West (1991), Dawson (2013) and Dawson and Richter (2006).  
Results 
Univariate results  
Gene-Brain Associations SNP (DRD1rs686, DRD2rs12364283, ANKK1rs1800497, and 
PPP1R1Brs87694), and ROI (VS, medial and lateral OFC) associations were assessed using 
univariate regression models, while controlling for Sex, Age, and imaging site (corrected for 
multiple comparisons, B-H, p<.0125). All regression results are presented in Table S2. This 
analysis yielded two significant associations.  First, DRD1rs686 reliably predicted medial OFC 
BOLD signal (Beta = -.08, t = -2.7, p = .008) to the large reward anticipation cue (F(10, 1230) = 6.5, 
p < .001, r2= .05,), indicating that increasing the number of G allele was associated with a 
stronger medial OFC BOLD response to the large reward anticipation cue (see Figure 2, middle 
panel). It is also worth noting that DRD1rs686 also predicted medial OFC BOLD response to small 
reward anticipation, (Beta = -.07, t = -2.4, p = .014), but this relationship did not survive our 
correction for multiple-comparisons.   Second, ANKK1rs1800497 significantly predicted lateral 
OFC BOLD, (Beta = -.09, t = -3.1, p = .002) response to the large reward anticipation cue (F(10, 
1227) = 2.9, p < .001, r
2= .03), indicating that increasing the number of A2 alleles was associated 
with a larger decreases in lateral OFC BOLD signaling during large reward anticipation (see 
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Figure 2, bottom panel). It is also worth noting that these SNPROI relationships remained 
significant (ANKK1rs1800497  [Beta = -.11, t = -3.1, p = .002]; DRD1rs686 [Beta = -.08, t = -2.3, p = 
.01]) when AUDIT Zone 0 participants (i.e. reported never using alcohol) were the only 
participants included in the regression analysis, suggesting that this genetic influence on reward 
activity precedes alcohol use at age 14.  
***Figure 2 here*** 
 
Figure 2. Gene-dose effects. DRD1 (left panel) and ANKK1 (right panel) gene-dose effects on 
small (clear columns) and large (dashed columns) reward anticipation cues for ventral striatum 
(top panel, green bars), medial OFC (middle panel, blue bars), and lateral OFC (bottom, red 
bars). Associated ROIs are displayed in right box. Error bars indicate standard errors of the 
means. OFC-orbital frontal cortex 
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  Brain-AUDIT Associations The relationship between reward anticipation (large and 
small) and AUDIT scores (Time 1 and Time 2) were assessed using univariate regression models 
(corrected for multiple comparisons, B-H, p<.0125). All regression results are presented in Table 
S3. While the ROIs did not uniquely predict AUDIT scores at either time point, this analysis 
demonstrated that the interaction between medial OFC and VS (Beta = .09, t = 2.98, p < .005; 
F(10, 1079) = 5.3, p < .001, r
2= .05) and lateral OFC and VS (Beta = .08, t = 2.6, p < .01; F(10, 1079) = 
5.3, p < .001, r2= .05) during high reward anticipation uniquely predicted alcohol misuse at 14 
years of age. No other associations were observed (p>.1). The finding suggests that when both 
the medial OFC and VS are highly active or inactive (i.e., synergistic), individuals displayed 
higher levels of Audit scores at 14 years of age (Figure 3C). It is interesting to note that the rs686 
SNP of the DRD1 gene reliably predicted both medial OFC and VS interaction (Beta = -.10, t = -
3.4, p < .001) for the large reward anticipation condition (F(10, 1230) = 4.3, p < .001, r2= .03)
2, and 
AUDIT scores (Beta = .07, t = 2.7, p = .008) at Time 2, (F(10, 1385) = 4.3, p < .001, r2= .03).          
SEM results 
***Figure 3 here*** 
                                                          
2 As a check, we tested all other SNP and OFC*VS interaction associations (Table S4). No associations were 
detected between the SNPs and the interaction between medial OFC and VS, p>.1, as well as the interaction 
between lateral OFC and VS, p>.1. 
IMAGEN 16  
 
Figure 3. Results of the SEM A) Significant direct and indirect paths between gene, brain and 
alcohol misuse. Paths that are part of significant indirect effects are highlighted in orange, other 
direct effects are shown in black. * P<.05, **P<.005, ***p < .001 (two-tailed). B) DRD1 
genotypes plotted by individuals classified as high medial OFC and high VS. C) Audit scores at 
14 years plotted by groups classified as high and low medial OFC and VS activation during large 
reward anticipation. Note: VS-ventral striatum, OFC-orbital frontal cortex. 
In the hypothesized model, all brain variables with genetic predictors were modeled to 
predict alcohol misuse at 14 years of age, which in turn predicted alcohol misuse at 16 years of 
age. Results from the SEM analysis showed that this model fit the data very well, X2 (21, 2052) = 
29.69; CFI = .97; TLI = .95; RMSEA = .014 (90%CI= .00 - .025); SMRM = .018. The model 
indicated that the medial OFC*VS interaction term calculated for the large reward condition 
predicted alcohol use at 14 years of age (Beta = .08, t = 2.9, p<.01), which in turn significantly 
predicted alcohol use at 16 years (Beta = .39, t = 13.57, p <.001). In order to better understand 
the interaction effects, a Chi-Square Test of Independence was conducted and indicated that the 
DRD1rs686 genotypes differ in the medial OFC*VS interaction, Χ2 (4, 1396) = 12.85, p =.012, 
namely, GG carriers, more than GA and AA carriers, were classified as high medial OFC and 
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high VS (15%, 10%, and 7% respectively) (Figure 3B). Furthermore, the interaction effect on 
alcohol use at 14 years was plotted (see Figure 3C), which indicated that when both the medial 
OFC and VS are highly active or inactive (i.e., synergistic), individuals displayed higher levels 
of Audit scores at 14 years of age. Finally, two significant indirect effects/paths from genes to 
alcohol misuse were identified: from rs686 SNP of the DRD1, through the medial OFC*VS 
interaction, to alcohol misuse at 14 years (ab= -.006, se=.003, 95% CI=-.013, -.01), and then on 
to alcohol misuse at 16 years (abc= -.002, se=.001, 95% CI= -.005, -.001) (Figure 3 A, orange 
path). 
Discussion 
Human neuroimaging studies confirm that the reward function of the mesocorticolimbic 
system is altered in substance use disorders (Volkow et al., 2011; Volkow et al., 2012).  
However, these data cannot distinguish whether the abnormalities observed in adults are induced 
by drug exposure or represent a pre-existing condition that predispose individuals to drug 
addiction, or a combination of both (Schoenbaum & Shaham, 2008; Schneider et al., 2012). In 
the present study, we attempted to resolve this issue by examining the relationship between 
dopaminergic functional polymorphisms, VS and OFC reward functioning, and alcohol use 
behaviour in early adolescence.  
Foremost, we found a novel association between the DRD1rs686 (Huang & Li, 2009) and 
medial OFC activation during reward anticipation: reducing DRD1 expression (increasing G 
alleles)(Huang & Li, 2009) predicted an increase in medial OFC response (but not lateral OFC or 
VS) to reward predicting cues. This finding appears consistent with a plethora of evidence 
highlighting the role of D1 receptors and medial OFC in reward-related learning (Cetin et al., 
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2004; Durstewitz & Seamans, 2002; Hikosaka & Watanabe, 2000; Frank & Claus, 2006; Elliott 
et al., 2008; Elliott et al., 2000). Further, D1 density differs quantitatively between sub-
compartments of the frontal cortex with the highest expression in the medial OFC (Hurd et al., 
2001). Our findings suggest that a reduction in DRD1rs686 expression may allow a greater 
proportion of D1 housing medial OFC neurons to become stimulated by dopaminergic reward 
signals, thereby intensifying its hemodynamic response. Although suggestive, this idea aligns 
with the proposal that the intensity of a reward response depends on the absolute number of 
interactions between dopamine and its post-synaptic D1 (or D2) receptors (Cox et al., 2015)pg. 99, 
and further, with evidence demonstrating that when D1 receptors are more highly activated in 
OFC, behaviours becomes more focused, and reward associations learned more rapidly (Garske 
et al., 2013). Taken together, this novel finding revealed that variation in expression DRD1rs686 
can modulate the reward response of the medial OFC. 
Perhaps more intriguing was the SEM findings, which point to a specific molecular 
pathway by which DRD1rs686 modulated the balance of activity between medial OFC and VS 
during reward anticipation, and this specific balance of activity predicted the level of problematic 
alcohol use behaviours early in adolescence. Consistent with anatomical, functional, and 
computational evidence highlighting the interplay between medial OFC and VS during learning 
(Pujara & Koenigs, 2014), a synergistic (hypo or hyper) response between medial OFC and VS 
during reward anticipation predicted elevated levels of problematic alcohol use behaviours. Such 
a synergistic relationship of activity between medial OFC and VS are interesting in light of 
known differential developmental trajectories for these regions in relation to reward processing 
and to increased risky behaviour during adolescents (Galvan et al., 2006). In particular, 
differential recruitment of frontostriatal regions are typically interpreted in terms of immature 
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prefrontal regions or an imbalance between prefrontal and subcortical regions (Galvan et al., 
2006), a developmental pattern proposed to be exacerbated in those adolescents with a 
predisposition toward risk-taking  (Galvan et al., 2006; Casey, 2015; Casey et al., 2008; Galvan 
et al., 2006). However, our results seem to suggest that a synergistic recruitment of medial OFC 
and VS during reward processing may facilitate a progression towards excessive drug use 
behaviours in adolescents.  
Notably, the relationship between a synergistic medial OFC and VS reward response and 
problematic alcohol use may be explained in the context of a recent dual system model of 
decision making, which refers to the competition between an automatic and deliberative system 
during learning (McClure & Bickel, 2014). According to this model, behaviours reflected in VS 
and OFC circuitry (the automatic system) develop slowly through the regular co-occurrence of 
stimuli and reinforcers, a process facilitated by positive (increase in dopamine activity) or 
negative (decrease in dopamine activity) reward prediction error (RPE) signals (Schultz, 2010). 
With sufficient experience, this learning process is thought to give rise to stereotyped or habitual 
(automatic) behaviours (McClure & Bickel, 2014). By contrast, the role of the deliberative 
system, comprised of the dorsal lateral prefrontal/posterior parietal cortex, is to modulate 
behaviours by down regulating value-related responses in the automatic behavioural system 
(McClure & Bickel, 2014).  
In line with this model, we propose that an automatic system with low DRD1 expression 
may function at a supraoptimal reward state during positive RPE signalling, allowing behaviours 
to become more focused, and associations learned more rapidly (for example, see Garske et al. 
2013). Further, the dopamine-potentiation effects of addictive substances would compound this 
problem, resulting in an exaggerated reward response by the automatic system. Such a 
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maladaptive process may in turn prevent the deliberative system to sufficiently compete in the 
decision making process, failing to down regulate and implement control over high-valued drug-
related stereotype, possibly explaining how early drug use can quickly spiral to problematic use. 
Alternatively, an automatic system with high DRD1 expression may function at a suboptimal 
reward state and antagonize positive RPE signalling. In turn, the automatic system may bias  
behaviours that are highly rewarding (e.g. following high risk behaviours, drug use) to 
compensate for a chronically low “reward” state (Blum et al., 2000; Comings & Blum, 2000). 
Furthermore, the deliberative system may fail to recognize the need to down regulate such high 
value-related responses by the automatic system since these reward responses may appear 
normalized. Although speculative, the association between a synergistic response between 
medial OFC and VS by DRD1rs686 (Huang & Li, 2009), and early onset of alcohol misuse 
behaviour may provide initial support for such possibilities.   
A challenging question is why this pattern of activation between the medial OFC and VS 
directly predicted AUDIT scores at 14 years of age, and mediated the effect between the 
DRD1rs686 and AUDIT scores at 16 years of age. Presently we can only speculate about the 
answer to this riddle. In regards to the former, it is important to point out that the relationship 
between the pattern of activation between medial OFC and VS, and AUDIT scores at 14 years of 
age preceded early alcohol use (see results), providing an explanation of how dopamine-related 
genes may predispose individuals to alcohol misuse. In regards to the latter, given the critical 
developmental period that the frontal and striatal brain systems go through between 14 and 16 
years of age, and taking into account the impact alcohol use may have during this time period, 
perhaps imaging data at 16 years of age may provide better predictions of AUDIT scores at Time 
2, as well as other risky behaviors. Alternatively, these findings could also be interpreted in the 
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context of the many type I errors observed in candidate gene studies. Nevertheless, we hope that 
the results of this study will motivate future research on this issue. 
The D2 dopamine receptor (DRD2) gene has received the most attention as a risk 
candidate for the genetic transmission of substance use disorders, yet, we did not observe such an 
association in this adolescent sample. Instead we observed that an increase in A2 alleles of the 
ANKK11800497 gene (Thompson et al., 1997) was associated with an increase in lateral OFC 
deactivation or suppression during reward anticipation. To note, this association is complicated 
by the difficulty in determining whether suppression or deactivations reflect an active process 
such as inhibition, a passive consequence of the redistribution of blood as activity is orchestrated 
within a distributed network (i.e. due to increase medial OFC activation) or a product of the 
baseline (Frankenstein et al., 2002). Nevertheless, increasing A2 alleles, which have been 
associated with an increase in D2 density, may have strengthened the D2 inhibitory signal in 
lateral OFC, thereby reducing neuronal excitability for the purpose of suppressing competing 
behavioural responses maintained in working memory (Elliott et al., 2000; Elliott & Deakin, 
2005). Based on these findings, perhaps D2’s role in addiction is only observed in later stages of 
addiction (Blum et al., 1993; Noble et al., 1994; Munafo et al., 2007), which might be through 
impaired inhibitory control by lateral OFC. For instance, in a drug-using state (elevated 
dopamine levels), the lateral OFC should serve to inhibit the execution of competing behaviours 
to promote heighted drug-seeking behaviour.  In an abstinent state (reduced dopamine levels), 
the lateral OFC may be unable to suppress drug-related behaviours that are not aligned with 
prosocial goals. Although speculative, how genetic variants related to D2 expression translate 
into a vulnerability to addiction warrants continued research.   
Conclusion 
IMAGEN 22  
Adolescence is thought to constitute a critical developmental period during which the 
frontal and striatal brain systems implicated in decision-making are particularly vulnerable to the 
addictive properties of drugs (Castellanos-Ryan et al., 2014; Conrod & Nikolaou, 2016). Our 
study provides a potential genetic link to this vulnerability, supporting the possibility that 
alterations in OFC and VS signalling by DRD1rs686 render youth susceptible to the early onset of 
substance misuse. Specifically, a genetic profile contributing to the presence of a suboptimal or 
supraoptimal balance between OFC and VS may present a primary risk factor of drug-seeking 
behaviour. Although speculative, it is possible that our findings may reflect a maladaptive U-
shaped tuning of reciprocal projections between these brain regions during reward functioning 
(e.g., motivated behavior, working memory, and reward related learning) and dopamine 
signalling (e.g., dopamine concentration, dopamine receptor availability) (Cools & D'Esposito, 
2011). By moving out of the optimum level of dopaminergic stimulation (trough) towards either 
peak by excessive or low levels of dopamine stimulation, the mesocorticolimbic system may 
become hyper or hypo sensitive to rewarding events, possibly biasing the adolescent's action 
toward drug-related behaviours. Lastly, our results point to a regional specificity in the 
relationship between functional polymorphisms associated with D1 and D2 receptors and 
reward-related activity in the medial and lateral OFC, respectively. By identifying such a 
dopamine-related genetic path in adolescence, our study points to targets for intervention at the 
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